Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity  Fuad S. Shihab, Hong Yi, William M. Bennett, Takeshi.

Slides:



Advertisements
Similar presentations
Volume 59, Issue 4, Pages (April 2001)
Advertisements

Effects of suppressing intrarenal angiotensinogen on renal transforming growth factor- β1 expression in acute ureteral obstruction  Gyu-Tae Shin, Wook-Hwan.
Volume 76, Issue 1, Pages (July 2009)
Volume 53, Issue 4, Pages (April 1998)
The aging kidney Kidney International
Volume 56, Issue 4, Pages (October 1999)
Volume 54, Issue 3, Pages (September 1998)
Volume 129, Issue 1, Pages (July 2005)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 55, Issue 1, Pages (January 1999)
Volume 55, Issue 5, Pages (May 1999)
Volume 56, Issue 1, Pages (July 1999)
Volume 58, Issue 6, Pages (December 2000)
Volume 63, Issue 4, Pages (April 2003)
Volume 67, Issue 3, Pages (March 2005)
TGF-β isoforms in renal fibrogenesis
Volume 62, Issue 1, Pages (July 2002)
Volume 60, Issue 3, Pages (September 2001)
Volume 61, Issue 6, Pages (June 2002)
Volume 56, Issue 5, Pages (November 1999)
Volume 65, Issue 6, Pages (June 2004)
Volume 64, Issue 2, Pages (August 2003)
Volume 61, Issue 5, Pages (May 2002)
Volume 65, Issue 6, Pages (June 2004)
Hiroyuki Yanagisawa, Nobuyuki Yamazaki, Gen Sato, Osamu Wada 
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Volume 57, Issue 6, Pages (June 2000)
Volume 63, Issue 2, Pages (February 2003)
Gene transfer of truncated IκBα prevents tubulointerstitial injury
A novel model to study renal myofibroblast formation in vitro
Volume 54, Pages S136-S138 (September 1998)
Volume 62, Issue 2, Pages (August 2002)
Volume 82, Issue 8, Pages (October 2012)
Volume 55, Issue 2, Pages (February 1999)
Volume 79, Issue 10, Pages (May 2011)
Lane J. Brunner, William M. Bennett, Dennis R. Koop 
Volume 57, Issue 5, Pages (May 2000)
Volume 61, Issue 1, Pages (January 2002)
Saulo Klahr, Jeremiah J. Morrissey  Kidney International 
Volume 56, Issue 3, Pages (September 1999)
Volume 66, Issue 5, Pages (November 2004)
Modulating kidney transplant interstitial fibrosis and tubular atrophy: is the RAAS an important target?  Hatem Amer, Matthew D. Griffin  Kidney International 
Volume 63, Issue 2, Pages (February 2003)
Volume 63, Issue 1, Pages (January 2003)
Volume 67, Issue 2, Pages (February 2005)
A role for leukotrienes in cyclosporine nephrotoxicity
Volume 54, Issue 4, Pages (October 1998)
Volume 68, Issue 2, Pages (August 2005)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 65, Issue 6, Pages (June 2004)
Volume 56, Issue 1, Pages (July 1999)
Volume 54, Issue 1, Pages (July 1998)
Protective effect of 20-hydroxyeicosatetraenoic acid (20-HETE) on glomerular protein permeability barrier  Ellen T. Mccarthy, R.A.M. Sharma, Mukut Sharma,
Volume 58, Issue 3, Pages (September 2000)
TGF-β type II receptor deficiency prevents renal injury via decrease in ERK activity in crescentic glomerulonephritis  C.Y. Song, B.C. Kim, H.K. Hong,
Endothelin antagonists in renal disease
Volume 60, Issue 5, Pages (November 2001)
Volume 58, Issue 5, Pages (November 2000)
Volume 56, Issue 6, Pages (December 1999)
Sequential effects of high glucose on mesangial cell transforming growth factor-β1 and fibronectin synthesis  Jong Hoon Oh, Hunjoo Ha, Mi Ra Yu, Hi Bahl.
Volume 70, Issue 11, Pages (December 2006)
Volume 69, Issue 2, Pages (January 2006)
Molecular and structural consequences of early renal allograft injury
Volume 59, Issue 6, Pages (June 2001)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
T-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis  Masashi Haraguchi, Wayne A. Border, Yufeng Huang,
Volume 59, Issue 2, Pages (February 2001)
Volume 65, Issue 6, Pages (June 2004)
Volume 65, Issue 1, Pages (January 2004)
Presentation transcript:

Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity  Fuad S. Shihab, Hong Yi, William M. Bennett, Takeshi F. Andoh  Kidney International  Volume 58, Issue 3, Pages 1174-1185 (September 2000) DOI: 10.1046/j.1523-1755.2000.00273.x Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 1 Histologic changes in experimental chronic cyclosporine (CsA) nephrotoxicity. Photomicrographs showing the renal cortex of a salt-depleted rat given olive oil (VH, vehicle; A), CsA at 7.5 mg/kg/day (B), a combination of CsA at 7.5 mg/kg/day andL-arginine (L-Arg) at 1.7 g/kg/day (C), or a combination of CsA at 7.5 mg/kg/day and N-nitro-L-arginine-methyl ester (L-NAME) at 3.5 mg/kg/day (D) for 28 days. In rats treated with only CsA, interstitial fibrosis and tubular atrophy are seen relative to a medullary ray. When both CsA and L-Arg are given in combination, the interstitial fibrosis and tubular atrophy are less severe. In contrast, when both CsA and L-NAME are given in combination, the interstitial fibrosis and tubular atrophy are much more extensive (trichrome, magnification ×100). Kidney International 2000 58, 1174-1185DOI: (10.1046/j.1523-1755.2000.00273.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 2 Northern blots of mRNA from the cortex of salt-depleted rat kidneys. Representative gel of total RNA isolated from whole cortex at 28 days from rats treated with CsA (7.5 mg/kg/day), CsA + L-NAME (3.5 mg/kg/day), CsA + L-Arg (1.7 g/kg/day), VH, VH + L-NAME, and VH + L-Arg. RNA was hybridized with cDNA probes to TGF-β1, PAI-1, biglycan, type I collagen, type IV collagen, and GAPDH. Molecular size markers are shown on the right. Abbreviations are as follows: CsA, cyclosporine; L-NAME, N-nitro-L-arginine-methyl ester; L-Arg, L-arginine; VH, placebo. Kidney International 2000 58, 1174-1185DOI: (10.1046/j.1523-1755.2000.00273.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 3 Northern blot expression of transforming growth factor-β1 (TGF-β1) mRNA in rat kidneys relative to GAPDH. Total RNA was isolated from whole cortex at 7 and 28 days and was hybridized with a cDNA probe to TGF-β1. Abbreviations are as follows: CsA, cyclosporine; L-NAME, N-nitro-L-arginine-methyl ester; L-Arg, L-arginine; VH, placebo. N = 6 per group. *P < 0.05 vs. VH; #P < 0.05 vs. CsA. Kidney International 2000 58, 1174-1185DOI: (10.1046/j.1523-1755.2000.00273.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 4 Expression of PAI-1 in CsA and VH treated rat kidneys. (A) Total RNA was isolated from whole cortex at 7 and 28 days and was hybridized with a cDNA probe to PAI-1. (B) PAI-1 protein expression was determined by ELISA from whole cortex homogenates. Abbreviations are in the legend to Figure 3 (N = 6 per group). *P < 0.05 vs. VH; #P < 0.05 vs. CsA. Kidney International 2000 58, 1174-1185DOI: (10.1046/j.1523-1755.2000.00273.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 5 Northern blot expression of biglycan mRNA in rat kidneys relative to GAPDH. Total RNA was isolated from whole cortex at 7 and 28 days and was hybridized with a cDNA probe to biglycan. Abbreviations are in the legend to Figure 3 (N = 6 per group). *P < 0.05 vs. VH; #P < 0.05 vs. CsA. Kidney International 2000 58, 1174-1185DOI: (10.1046/j.1523-1755.2000.00273.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 6 Fibronectin protein expression by ELISA in rat kidneys. PAI-1 protein expression was determined by ELISA from whole cortex homogenates. Abbreviations are in the legend to Figure 3 (N = 6 per group). *P < 0.05 vs. VH; #P < 0.05 vs. CsA. Kidney International 2000 58, 1174-1185DOI: (10.1046/j.1523-1755.2000.00273.x) Copyright © 2000 International Society of Nephrology Terms and Conditions

Figure 7 Northern blot expression of collagen type I and type IV mRNA in rat kidneys relative to GAPDH. Total RNA was isolated from whole cortex at 7 and 28 days and was hybridized with a cDNA probe to collagen type I (A) or type IV (B). Abbreviations are in the legend to Figure 3 (N = 6 per group). *P < 0.05 vs. VH; #P < 0.05 vs. CsA. Kidney International 2000 58, 1174-1185DOI: (10.1046/j.1523-1755.2000.00273.x) Copyright © 2000 International Society of Nephrology Terms and Conditions